Jobs / United States / Astrazeneca Pharmaceuticals Lp

Astrazeneca Pharmaceuticals Lp

Senior Scientist, Clinical AI Research & Evaluation (Regulatory & Responsible AI)

US - Cambridge Kendall SQ - MA Posted today

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Skills this job asks for

LLMsTranslationCompliance

Add your CV (free) to see which of these your CV is missing.

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles10 certified filings for “Scientist, Cancer Immunology, Oncology Research” (Biochemists and Biophysicists) in MD: $104k–$138k, median $130k.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles
10 certified filings for “Scientist, Cancer Immunology, Oncology Research” (Biochemists and Biophysicists) in MD: $104k–$138k, median $130k. Most were filed at wage level II (60%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

We're building a connected, end-to-end  Enterprise AI  engine - uniting data foundations, AI technology, process reinvention, and business-facing AI to accelerate results across the whole value chain.  Success depends on being exceptional connectors : you'll actively leverage existing capabilities, celebrate and promote reuse, export breakthrough ideas across geographies and functions, and obsess over scaling impact rather than building in isolation. If you thrive in high-collaboration environments where your role is to turn complex, cross-functional problems into reusable, enterprise-wide capabilities - and where the measure of success is adoption and scale, not just innovation - you'll have the platform (and sponsorship) to make it real.  About AISI AI Science & Innovation (AISI) sits at the centre of AstraZeneca's R&D AI transformation within Enterprise AI Unit (EAI). Our remit is to build, buy, and deliver the AI models and agents that change pipeline outcomes across discovery, translational science, biomarkers, and clinical development, ultimately improving patients' lives. The opportunity We are building an end-to-end Enterprise AI engine that unites data foundations, AI models, platforms, and business-facing applications to accelerate results across the value chain. Success comes from reusing what already works, sharing ideas across teams, and scaling impact rather than building in isolation. Role overview AstraZeneca is building an AI capability for Clinical Development that will change how trials are designed, conducted, monitored, and analyzed. We are hiring a Senior Scientist, Clinical AI Research & Evaluation to do two things: advance the science of evaluating clinical AI systems as a hands-on researcher, and act as a technical AI advisor to Regulatory Affairs. The role is based in Cambridge, MA. This is primarily a researcher-first role with a secondary responsibility towards regulatory AI guidance. In your primary identity as an AI researcher, you design and run evaluations of LLM-based and agentic clinical systems such as benchmarks, evaluation harnesses, LLM-as-judge methods, failure analysis, and you do it in code, alongside the Clinical AI Applied Science & Translation team. Your second hat is technical advisor to Regulatory: you translate evaluation evidence, reliability, responsible-AI practice, and residual risk into language and evidence standards that Regulatory colleagues can act on, and you help bring validation thinking in early, before the design is locked. You will work day to day with the team building agentic workflows for clinical-trial planning, conduct, monitoring, and review, and you will spend a meaningful share of your time with Regulatory, Quality, and compliance colleagues. GxP expertise is not a must have for this role. We're looking for a strong researcher who wants to learn the evidentiary standards of regulated medicine and apply their evaluation skills there. What you'll do AI research & evaluation (primary, the majority of the role) Design and run evaluations of LLM-based and agentic clinical systems: benchmark construction, evaluation harnesses, LLM-as-judge methods with judge calibration, failure-mode taxonomies, red-teaming, and error analysis. Build reusable evaluation assets (test sets, scoring rubrics, annotation protocols, regression suites, analysis pipelines) that the portfolio can reuse across studies and therapeutic areas. Study how AI output shapes clinical judgment: expert-agreement studies, user studies, reliability under noisy, incomplete, or context-dependent ground truth. Investigate failures using traces, logs, qualitative review, and quantitative analysis; translate findings into model, prompt, tool, data, or workflow improvements. Publish and communicate finding

Apply on employer site ↗